GASTROINTESTINAL INFECTIONS: Edited by Nicholas J. Beeching and A. Clinton WhiteUpdate on the burden of Campylobacter in developing countriesPlatts-Mills, James A.a; Kosek, Margaretb Author Information aDivision of Infectious Diseases and International Health, University of Virginia Health System, Charlottesville, Virginia bDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA Correspondence to James A. Platts-Mills, MD, Division of Infectious Diseases and International Health, University of Virginia Health System, P.O. Box 801363, Charlottesville, Virginia 22908, USA. Tel: +1 434 243 6832; fax: +1 434 924 0075; e-mail: [email protected] Current Opinion in Infectious Diseases 27(5):p 444-450, October 2014. | DOI: 10.1097/QCO.0000000000000091 Buy Metrics Abstract Purpose of review Recent work has added to the understanding of the burden of Campylobacter jejuni, C. coli, and non-jejuni/coli Campylobacter strains in children living in the developing world. Recent findings New diagnostic modalities and carefully designed field studies are demonstrating that the burden of Campylobacter diarrhea in children in the developing world has been greatly underestimated. Furthermore, there is emerging recognition of an association between Campylobacter infection and malnutrition. Important progress has been made toward a Campylobacter jejuni vaccine. Finally, evidence of antibiotic resistance continues to be an important issue that is accentuated by the realization that the burden of disease is greater than previously recognized. Summary Additional research is needed to refine our understanding of the epidemiology of Campylobacter infections in developing countries, in particular to improve estimates of the burden of Campylobacter diarrhea in endemic settings, to determine the impact of recurrent Campylobacter infections on child development, and to describe the prevalence and clinical significance of non-jejuni/coli Campylobacter infections. Progressive antibiotic resistance of isolates argues for augmented and expanded control measures of antibiotics in livestock. Continued work in vaccine development is warranted as is the extension of data available on the serotypes related to burden in different areas of the world and the relationship of serotypes to disease severity. © 2014 Lippincott Williams & Wilkins, Inc.